Rituximab desensitization protocol in a child with secondary lymphoproliferative disease

Ann Allergy Asthma Immunol. 2019 Nov;123(5):526. doi: 10.1016/j.anai.2019.09.004.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Child
  • Connective Tissue Diseases*
  • Desensitization, Immunologic
  • Humans
  • Lymphoproliferative Disorders*
  • Neoplasms*
  • Rituximab

Substances

  • Rituximab